Gedeon Charlotte, Sandell Mikael, Birkemose Inge, Kakko Johan, Rúnarsdóttir Valgerður, Simojoki Kaarlo, Clausen Thomas, Nyberg Fred, Littlewood Richard, Alho Hannu
Solstenen Addiction Centre, Skåne, Sweden.
Capio Maria, Stockholm and Skåne, Sweden.
Nordisk Alkohol Nark. 2019 Jun;36(3):286-298. doi: 10.1177/1455072518815322. Epub 2019 Jan 27.
Outcomes in opioid use disorder (OUD) in Nordic countries have improved with integrated treatment and harm-reduction programmes. Approaches and the standard of care are different across the region. Evidence of treatment needs and current approaches are defined from evidence to inform development of a common standard.
Evidence of population sizes and treatment approach collected. Common standards for care (harm reduction, pharmacotherapy, psychology/social therapy) defined for each country.
Evidence defines number in treatment; potential population needing treatment not defined for all countries. Populations sizes, treatment access (ratio in treatment programme compared to total country population) defined: Sweden 4,000 in OUD care (access ratio 40); Finland 3,000 (55); Norway 8,000 (154); Denmark 7,500 (132). Approach to treatment similar: integrated treatment programmes standard. Care provided by specialists in outpatient clinics/primary care; secondary care/inpatient services are available. Harm reduction is limited in Sweden but available and more accessible elsewhere. Treatment entry criteria: access relatively unlimited in Norway and Denmark, more limited in Finland and Sweden. Standards of care defined: easy access to high-quality services, individual planning, care not limited by time, management of relapse, education for patients, continuous engagement, holistic approach including management of comorbidities, needle equipment programmes without limit, treatment in prisons as community.
There are opportunities to improve OUD care in the Nordics. Policy makers and clinicians can advance OUD care and share common success factors. Collaborative work across the Nordic countries is valuable. Further research in clinical practice development can yield important results for the benefit of patients with OUD.
北欧国家通过综合治疗和减少伤害计划,阿片类物质使用障碍(OUD)的治疗效果有所改善。该地区的治疗方法和护理标准各不相同。确定治疗需求和当前方法的证据,以便为制定通用标准提供依据。
收集人口规模和治疗方法的证据。为每个国家定义护理通用标准(减少伤害、药物治疗、心理/社会治疗)。
证据确定了接受治疗的人数;并非所有国家都确定了需要治疗的潜在人群。确定了人口规模、治疗可及性(治疗项目中的人数与国家总人口的比例):瑞典有4000人接受OUD护理(可及性比例为40);芬兰有3000人(55);挪威有8000人(154);丹麦有7500人(132)。治疗方法相似:综合治疗项目为标准。由门诊诊所/初级保健的专科医生提供护理;提供二级护理/住院服务。瑞典的减少伤害措施有限,但在其他地方可用且更容易获得。治疗准入标准:挪威和丹麦的准入相对不受限制,芬兰和瑞典则更有限。确定的护理标准:易于获得高质量服务、个性化规划、护理不受时间限制、复发管理、患者教育、持续参与、包括合并症管理的整体方法、无限制的针头设备项目、在监狱中作为社区进行治疗。
北欧地区有改善OUD护理的机会。政策制定者和临床医生可以推进OUD护理并分享共同的成功因素。北欧国家之间的合作工作很有价值。临床实践发展方面的进一步研究可为OUD患者带来重要成果。